Analgea SR is effective in complete resolution of pain in the majority of patients for 3-4 days with a single application.
Chronic wounds are those that have failed to heal after 3 months of appropriate wound care. They are classified into 4 categories: pressure ulcers, diabetic ulcers, venous ulcers and arterial insufficiency ulcers.
Approximately 6.5 million people in the United States experience chronic wounds causing considerable pain and affecting quality of life.
Studies show that 69% of chronic wounds are significantly painful.
Many of these patients are treated with opioids which have high potential for abuse & addiction.
Cost associated with chronic wounds is estimated at $25 billion per year in the United States.
Costs will continue to grow as the population ages and the number of chronic wounds increases.
Treatment of opioid dependence cost the US an estimated $504 billion in 2015.
Analgea SR
Indicated for use in the management of pain in partial or full thickness wounds including: diabetic ulcers, venous stasis ulcers, pressure ulcers, surgical wounds, ischemic ulcers, traumatic wounds, first and second degree burns, superficial wounds, abrasions, and lacerations.